Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

Prestigious World Congress of Neurology Returns In-Person to Convene World-Class Researchers in Montreal

MONTREAL, Oct. 12, 2023 /PRNewswire/ -- The World Federation of Neurology (WFN) and the Canadian Neurological Society (CNS) will host theXXVI World Congress of Neurology (WCN) in Montreal, Canada, from October 15 to 19, 2023. WCN is a major, biennial conference where world-class neurologists and ...

2023-10-12 18:00 1557

Saving on Health Insurance in Hong Kong with NowCompare.com.hk

HONG KONG, Oct. 11, 2023 /PRNewswire/ -- Health insurance is a critical aspect of financial planning, ensuring that individuals and families have access to quality healthcare without the burden of exorbitant medical expenses. InHong Kong, where the cost of healthcare can be quite high, finding th...

2023-10-12 14:38 1665

ALLORION THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1/2 STUDY OF ARTS-021, A POTENTIAL BEST IN CLASS CDK2 INHIBITOR, FOR ADVANCED OR METASTATIC SOLID TUMORS

NATICK, Mass., Oct. 12, 2023 /PRNewswire/ -- Allorion Therapeutics (Allorion), a clinical-stage biotechnology company dedicated to the discovery and development of next-generation targeted drugs for cancer and autoimmune diseases, announced today the dosing of its first patient in the Phase 1/2 ...

2023-10-12 10:37 1612

Suvoda Introduces Advanced Drug Optimization For IRT to Improve Accuracy of Clinical Trial Drug Supply Management

Greater Control Over Drug Supply Management Helps Sponsors Reduce Costs and Carbon Footprint PHILADELPHIA, Oct. 12, 2023 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), an...

2023-10-12 09:00 1927

Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test

SEOUL, South Korea, Oct. 12, 2023 /PRNewswire/ -- Gencurix , a cancer molecular diagnostics company, has obtained approval from the Australian Government (The Department of Health and Aged Care, Therapeutic Goods Administration) for its Droplex POLE Mutati...

2023-10-12 06:00 2014

CSL Signs Renewable-Linked Power Purchase Agreement with AGL to Supply Electricity to Australian Manufacturing Sites

MELBOURNE, Australia, Oct. 12, 2023 /PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) announced today thatit has signed a Renewable-Linked Power Purchase Agreement (PPA) with Australian energy provider, AGL.AGL was awarded the contract after an extensive review of the ener...

2023-10-12 05:00 3553

KHB Becomes First Chinese Company to Obtain EU Class D IVDR Certification for Its Rapid Test HIV Colloidal Gold Diagnostic Kit

SHANGHAI, Oct. 11, 2023 /PRNewswire/ -- Shanghai Kehua Bio-engineering Co., Ltd ("KHB" or "the Company", Stock code: 002022.SZ),China's leading In Vitro Diagnostic (IVD) company has achieved a significant milestone by becoming the first Chinese company to obtain EU Clas...

2023-10-11 16:27 2509

KHB Becomes First Chinese Company to Obtain EU Class D IVDR Certification for Its Rapid Test HIV Colloidal Gold Diagnostic Kit

Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich

LONDON, Oct. 11, 2023 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports medicine, is pleased to announce the opening of the purpose-built Smith+Nephew Academy Munich, a new centre for surgica...

2023-10-11 14:00 3351

Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich

EQT to acquire VetPartners, the leading provider of veterinary and animal health services in Australia and New Zealand

* EQT to acquire VetPartners, the leading provider of veterinary and animal health services across a network of 267 general practice clinics and specialty hospitals inAustralia and New Zealand * With a community of more than 1,300 highly skilled vets and over 3,000 nurses and cli...

2023-10-11 12:21 1994

Ascletis Announces Poster Presentation of Phase II Study Topline Results of FASN Inhibitor ASC40 for Treatment of Acne at EADV Congress 2023

HANGZHOU and SHAOXING, China, Oct. 11, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") today announces the poster presentation of Phase II study topline results of ASC40, a first-in-class fatty acid synthase (FASN) inhibitor for treatment of acne, at the European Academy of Der...

2023-10-11 08:10 2128

VISTA Eye Specialist Achieves International Recognition at European Congress

PETALING JAYA, Malaysia, Oct. 11, 2023 /PRNewswire/ -- Last September, VISTA Eye Specialist proudly marked its presence at the prestigious European Society of Cataract and Refractive Surgery (ESCRS) Symposium and Congress inVienna, Austria. This event, the second participation since the onset of ...

2023-10-11 08:00 2018

VISTA Eye Specialist Achieves International Recognition at European Congress

JUNG KWAN JANG launches student-specialized brand I.PASS for physical strength, immunity, and memory all at once

- The essential item that Korean parents with high enthusiasm over education provide for their children SEOUL, South Korea, Oct. 11, 2023 /PRNewswire/ -- I.PASS, a student-specialized brand that was renewed and launched through JUNG KWAN JANG red ginseng of KGC (Korea Ginseng Corp.), is a health...

2023-10-11 07:00 2598

EADV Congress: Non-melanoma skin cancer killing more people than melanoma, new study finds

BERLIN, Oct. 11, 2023 /PRNewswire/ -- Non-melanoma skin cancer (NMSC) is causing a greater number of global deaths than melanoma, the more serious form of skin cancer, a new study presented today at the EADV Congress 2023 has found. Researchers also believe that NMSC is underreported and that the...

2023-10-11 06:01 1866

SAFETYscan47: A Valuable Component in Revolutionizing Chemical Risk Assessments for Global Health and Safety

SAN DIEGO, Oct. 10, 2023 /PRNewswire/ -- Eurofins Discovery, an industry-leading provider of products and services for drug discovery research, today announced its SAFETYscan®47 platform as a New Approach Methodology (NAM), part of a standardized framework aiming to revolutionize chemical risk a...

2023-10-10 23:10 1944

Novel classification of allergic disorders published by the European Academy of Allergy and Clinical Immunology: SIAF

Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper published in 'Allergy' DAVOS, Switzerland, Oct. 10, 2023 /PRNewswire/ -- The revision of the current allergic disease nomenclature based on symptoms and organ dysfunction has been l...

2023-10-10 19:10 1401

Gates Foundation Celebrates 20 Years of "Grand Challenges" With New Investments and a Call to Make R&D Breakthroughs Available More Quickly and Equitably

Commitments focus on advancing equitable access to artificial intelligence (AI) and vaccines,and catalyzing innovations that address women's health SEATTLE and DAKAR, Senegal, Oct. 10, 2023 /PRNewswire/ -- A slate of new initiatives to support locally led innovation was announced today inDakar b...

2023-10-10 18:30 1597

Scorpion Therapeutics and Pierre Fabre Laboratories Announce First Patient Dosed in Phase 1/2 Clinical Trial of STX-721, a Mutant-Selective EGFR Exon 20 Inhibitor for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer

-- STX-721 is characterized by high selectivity and a potentially best-in-class profile -- -- Scorpion's second program to enter clinical development this year -- -- One of two EGFR programs being developed with Pierre Fabre Laboratories -- BOSTON and CASTRES, France, Oct. 10, 2023 /PRNewswire/...

2023-10-10 18:00 1572

Frost & Sullivan Launches the EmpowerHer Program to Bridge the Growth Gap in Women's Health

Global Think Tanks and Collaboration to Drive Innovation and Empowerment in Women's Health SAN ANTONIO, Oct. 10, 2023 /PRNewswire/ -- Frost & Sullivan, a renowned leader in fostering innovation and driving transformative change, proudly announces the launch of its groundbreaking"EmpowerHer" Grow...

2023-10-10 15:12 1314

Frost & Sullivan Launches the EmpowerHer Program to Bridge the Growth Gap in Women's Health

Recbio signed a strategic cooperation agreement with Zimbabwe National Biotechnology Administration and ICGEB China Regional Research Centre

TAIZHOU, China, Oct. 10, 2023 /PRNewswire/ -- On October 8, 2023, Dr. Deckster Tonny SAVADYE, CEO of Zimbabwe NBA, and Dr.Yang Yili, International Centre for Genetic Engineering and Biotechnology China Regional Research Centre(ICGEB), visited Recbio. Dr. SAVADYE and his team conducted an on-the-s...

2023-10-10 13:54 4513

Recbio signed a strategic cooperation agreement with Zimbabwe National Biotechnology Administration and ICGEB China Regional Research Centre

Fullerton Health and Connections MindHealth Recommend a Framework for Action to Enhance Mental Health at the Workplace

SINGAPORE, Oct. 10, 2023 /PRNewswire/ -- Fullerton Health & Connections MindHealth are pleased to announce the release of a Healthcare Brief that addresses critical challenges surrounding mental health in the workplace. Titled "A Framework for Action: Enhancing Mental Health in the Workplace", th...

2023-10-10 13:39 3853

Fullerton Health and Connections MindHealth Recommend a Framework for Action to Enhance Mental Health at the Workplace

1 ... 108 109 110111112 113 114 ... 570